{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:41:53Z","timestamp":1784126513126,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"DOI":"10.1186\/s12893-025-03355-0","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:47:39Z","timestamp":1767019659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Urine-based nematode chemotaxis assay (N-NOSE) as a predictor of recurrence after curative surgery for resectable pancreatic cancer: preliminary data and single center experience"],"prefix":"10.1186","volume":"25","author":[{"given":"Masahiro","family":"Fukada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriki","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Horaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Yasufuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse Yu","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Hasan","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Hirotsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"di Luccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Futamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Matsuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"11","key":"3355_CR1","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913\u201321.","journal-title":"Cancer Res"},{"issue":"10","key":"3355_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/jjco\/hyv088","volume":"45","author":"M Hori","year":"2015","unstructured":"Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H, Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the monitoring of cancer incidence in Japan (MCIJ) Project. Jpn J Clin Oncol. 2015;45(10):884\u201391.","journal-title":"Jpn J Clin Oncol."},{"issue":"3","key":"3355_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.6004\/jnccn.2019.0014","volume":"17","author":"MA Tempero","year":"2019","unstructured":"Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, et al. Pancreatic adenocarcinoma, version 1.2019 featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2019;17(3):203\u201310.","journal-title":"J Natl Compr Canc Netw."},{"issue":"134","key":"3355_CR4","first-page":"1756","volume":"61","author":"M Suenaga","year":"2014","unstructured":"Suenaga M, Fujii T, Kanda M, Takami H, Okumura N, Inokawa Y, et al. Pattern of first recurrent lesions in pancreatic cancer: hepatic relapse is associated with dismal prognosis and portal vein invasion. Hepatogastroenterology. 2014;61(134):1756\u201361.","journal-title":"Hepatogastroenterology"},{"issue":"5","key":"3355_CR5","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","volume":"267","author":"VP Groot","year":"2018","unstructured":"Groot VP, Rezaee N, Wu W, Cameron JL, Fishman EK, Hruban RH, et al. Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2018;267(5):936\u201345.","journal-title":"Ann Surg"},{"issue":"6","key":"3355_CR6","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1097\/SLA.0000000000002734","volume":"269","author":"VP Groot","year":"2019","unstructured":"Groot VP, Gemenetzis G, Blair AB, Rivero-Soto RJ, Yu J, Javed AA, et al. Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma. Ann Surg. 2019;269(6):1154\u201362.","journal-title":"Ann Surg"},{"issue":"1","key":"3355_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5009\/gnl.2014.8.1.102","volume":"8","author":"M La Torre","year":"2014","unstructured":"La Torre M, Nigri G, Lo Conte A, Mazzuca F, Tierno SM, Salaj A, et al. Is a preoperative assessment of the early recurrence of pancreatic cancer possible after complete surgical resection? Gut Liver. 2014;8(1):102\u20138.","journal-title":"Gut Liver"},{"issue":"5","key":"3355_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/cancers12010137","volume":"12","author":"N Kim","year":"2020","unstructured":"Kim N, Han IW, Ryu Y, Hwang DW, Heo JS, Choi DW, et al. Predictive nomogram for early recurrence after pancreatectomy in resectable pancreatic cancer: risk classification using preoperative clinicopathologic factors. Cancers (Basel). 2020;12(5):137.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"3355_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s11605-012-1859-9","volume":"16","author":"T Sugiura","year":"2012","unstructured":"Sugiura T, Uesaka K, Kanemoto H, Mizuno T, Sasaki K, Furukawa H, et al. Serum CA19-9 is a significant predictor among preoperative parameters for early recurrence after resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012;16(5):977\u201385.","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"3355_CR10","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.3390\/cancers12102970","volume":"12","author":"L Van Manen","year":"2020","unstructured":"Van Manen L, Groen JV, Putter H, Pichler M, Vahrmeijer AL, Bonsing BA, et al. Stage-specific value of carbohydrate antigen 19\u20139 and carcinoembryonic antigen serum levels on survival and recurrence in pancreatic cancer: a single center study and meta-analysis. Cancers (Basel). 2020;12(11):2970.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"3355_CR11","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1245\/s10434-009-0415-7","volume":"16","author":"M Waraya","year":"2009","unstructured":"Waraya M, Yamashita K, Katagiri H, Ishii K, Takahashi Y, Furuta K, et al. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer. Ann Surg Oncol. 2009;16(5):1231\u201340.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3355_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12957-016-1078-z","volume":"15","author":"K Nishio","year":"2017","unstructured":"Nishio K, Kimura K, Amano R, Yamazoe S, Ohrira G, Nakata B, et al. Preoperative predictors for early recurrence of resectable pancreatic cancer. World J Surg Oncol. 2017;15(1):16.","journal-title":"World J Surg Oncol"},{"issue":"2","key":"3355_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pan.2020.12.017","volume":"21","author":"L Sivapalan","year":"2021","unstructured":"Sivapalan L, Kocher HM, Ross-Adams H, Chelala C. Molecular profiling of ctDNA in pancreatic cancer: opportunities and challenges for clinical application. Pancreatology. 2021;21(2):363\u201378.","journal-title":"Pancreatology"},{"issue":"18","key":"3355_CR14","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.7150\/jca.24591","volume":"9","author":"Z-H Qi","year":"2018","unstructured":"Qi Z-H, Xu H-X, Zhang S-R, Xu J-Z, Li S, Gao H-L, et al. The significance of liquid biopsy in pancreatic cancer. J Cancer. 2018;9(18):3417\u201326.","journal-title":"J Cancer"},{"key":"3355_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejca.2019.10.020","volume":"124","author":"P Hammel","year":"2020","unstructured":"Hammel P, Fabienne P, Mineur L, Metges J-P, Andre T, De La Fouchardiere C, et al. Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: an open-label, randomized phase IIb trial. Eur J Cancer. 2020;124:91\u2013101.","journal-title":"Eur J Cancer"},{"key":"3355_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41416-019-0704-2","volume":"122","author":"S Guo","year":"2020","unstructured":"Guo S, Shi X, Shen J, Gao S, Wang H, Shen S, et al. Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patients. Br J Cancer. 2020;122:857\u201367.","journal-title":"Br J Cancer"},{"key":"3355_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/bjc.2016.175","volume":"115","author":"N Hadano","year":"2016","unstructured":"Hadano N, Murakami Y, Uemura K, Hashimoto Y, Kondo N, Nakagawa N, et al. Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer. Br J Cancer. 2016;115:59\u201365.","journal-title":"Br J Cancer"},{"key":"3355_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1158\/1078-0432.CCR-16-0806","volume":"23","author":"D Pietrasz","year":"2017","unstructured":"Pietrasz D, P\u00e9cuchet N, Garlan F, Didelot A, Dubreuil O, Doat S, et al. Plasma circulating tumor DNA in pancreatic cancer patients is a prognostic marker. Clin Cancer Res. 2017;23:116\u201323.","journal-title":"Clin Cancer Res"},{"key":"3355_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/1534735408319058","volume":"7","author":"G Horvath","year":"2008","unstructured":"Horvath G, J\u00e4rverud GAK, J\u00e4rverud S, Horv\u00e1th I. Human ovarian carcinomas detected by specific odor. Integr Cancer Ther. 2008;7:76\u201380.","journal-title":"Integr Cancer Ther"},{"key":"3355_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00404-012-2542-9","volume":"287","author":"BPC Goksedef","year":"2013","unstructured":"Goksedef BPC, Api M, Kaya O, Gorgen H, Tarlaci A, Cetin A. Diagnostic accuracy of two endocervical sampling method: randomized controlled trial. Arch Gynecol Obstet. 2013;287:117\u201322.","journal-title":"Arch Gynecol Obstet"},{"key":"3355_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1136\/gut.2010.218305","volume":"60","author":"H Sonoda","year":"2011","unstructured":"Sonoda H, Kohnoe S, Yamazato T, Satoh Y, Morizono G, Shikata K, et al. Colorectal cancer screening with odour material by canine scent detection. Gut. 2011;60:814\u20139.","journal-title":"Gut"},{"key":"3355_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1534735405285096","volume":"5","author":"M McCulloch","year":"2006","unstructured":"McCulloch M, Jezierski T, Broffman M, Hubbard A, Turner K, Janecki T. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther. 2006;5:30\u20139.","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"3355_CR23","doi-asserted-by":"publisher","first-page":"e0118699","DOI":"10.1371\/journal.pone.0118699","volume":"10","author":"T Hirotsu","year":"2015","unstructured":"Hirotsu T, Sonoda H, Uozumi T, Shinden Y, Mimori K, Maehara Y, et al. A highly accurate inclusive cancer screening test using Caenorhabditis elegans scent detection. PLoS ONE. 2015;10(1):e0118699.","journal-title":"PLoS ONE"},{"issue":"5","key":"3355_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/MPA.0000000000001814","volume":"50","author":"M Kobayashi","year":"2021","unstructured":"Kobayashi M, Fujita A, Ogawa T, Tanisaka Y, Mizuide M, Kondo N, et al. Caenorhabditis elegans as a diagnostic aid for pancreatic cancer. Pancreas. 2021;50(5):673\u20138.","journal-title":"Pancreas"},{"key":"3355_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","volume":"19","author":"MA Tempero","year":"2021","unstructured":"Tempero MA, Malafa MP, Al-Hawary M, Behrman SW, Benson AB, Cardin DB, et al. Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19:439\u201357. https:\/\/doi.org\/10.6004\/jnccn.2021.0017.","journal-title":"J Natl Compr Canc Netw"},{"issue":"13","key":"3355_CR26","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.3390\/cancers15153870","volume":"15","author":"Y Sato","year":"2023","unstructured":"Sato Y, Futamura M, Tanaka Y, Tsuchiya H, Fukada M, Higashi T, et al. Clinical possibility of Caenorhabditis elegans as a novel evaluation tool for esophageal cancer patients receiving chemotherapy: a prospective study. Cancers. 2023;15(13):3870.","journal-title":"Cancers"},{"issue":"13","key":"3355_CR27","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/cells14130950","volume":"14","author":"Y Tokumaru","year":"2025","unstructured":"Tokumaru Y, Niwa Y, Mori R, Okawa M, Nakakami A, Sato Y, et al. Application of N-NOSE for evaluating the response to neoadjuvant chemotherapy in breast cancer patients. Cells. 2025;14(13):950.","journal-title":"Cells"},{"issue":"8","key":"3355_CR28","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.6004\/jnccn.2017.0131","volume":"15","author":"MA Tempero","year":"2017","unstructured":"Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, et al. Pancreatic adenocarcinoma, version 2.2017: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15(8):1028\u201361.","journal-title":"J Natl Compr Canc Netw."},{"key":"3355_CR29","doi-asserted-by":"publisher","first-page":"103548","DOI":"10.1016\/j.critrevonc.2021.103548","volume":"169","author":"S Bunduc","year":"2022","unstructured":"Bunduc S, Gede N, V\u00e1ncsa S, Lillik V, Kiss S, Dembrovszky F, et al. Prognostic role of cell-free DNA biomarkers in pancreatic adenocarcinoma: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2022;169:103548.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3355_CR30","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.1038\/ncomms8686","volume":"6","author":"M Sausen","year":"2015","unstructured":"Sausen M, Phallen J, Adleff V, Jones S, Leary RJ, Barrett MT, et al. Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. Nat Commun. 2015;6:7686.","journal-title":"Nat Commun"},{"issue":"19","key":"3355_CR31","doi-asserted-by":"publisher","first-page":"9952","DOI":"10.3390\/ijms23179952","volume":"23","author":"AJA Freitas","year":"2022","unstructured":"Freitas AJA, Causin RL, Varuzza MB, Calfa S, Hidalgo Filho CMT, Komoto TT, et al. Liquid biopsy as a tool for the diagnosis, treatment, and monitoring of breast cancer. Int J Mol Sci. 2022;23(19):9952.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3355_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","volume":"15","author":"M Nikanjam","year":"2022","unstructured":"Nikanjam M, Kato S, Kurzrock R. Liquid biopsy: current technology and clinical applications. J Hematol Oncol. 2022;15(1):131.","journal-title":"J Hematol Oncol"},{"issue":"10","key":"3355_CR33","first-page":"2318","volume":"7","author":"T Lu","year":"2017","unstructured":"Lu T, Li J. Clinical applications of urinary cell-free DNA in cancer: current insights and promising future. Am J Cancer Res. 2017;7(10):2318\u201332.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"3355_CR34","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1186\/s12885-024-13327-x","volume":"24","author":"S Iitaka","year":"2024","unstructured":"Iitaka S, Kuroda A, Narita T, Hatakeyama H, Morishita M, Ungkulpasvich U, et al. Evaluation of N-NOSE as a surveillance tool for recurrence in gastric and esophageal cancers: a prospective cohort study. BMC Cancer. 2024;24(1):1544.","journal-title":"BMC Cancer"},{"key":"3355_CR35","doi-asserted-by":"publisher","first-page":"1179299X1989655","DOI":"10.1177\/1179299X19896551","volume":"11","author":"H Kusumoto","year":"2019","unstructured":"Kusumoto H, Tashiro K, Shimaoka S, Tsukasa K, Baba Y, Furukawa S, et al. Behavioural response alteration in Caenorhabditis elegans to urine after surgical removal of cancer: nematode-NOSE (N-NOSE) for postoperative evaluation. Biomark Cancer. 2019;11:1179299X19896551.","journal-title":"Biomark Cancer"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-025-03355-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:47:40Z","timestamp":1767019660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12893-025-03355-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3355"],"URL":"https:\/\/doi.org\/10.1186\/s12893-025-03355-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7492933\/v1","asserted-by":"object"}]},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the guidelines of the Declaration of Helsinki and approved by the ethics committees of Gifu University School of Medicine (ID: 2022\u20130107). Informed consent was obtained from all the patients before all study-related procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"596"}}